Virocan is an R&D driven company actively engaged in developing and acquiring intellectual property. Virocan has been aggressive in creating and protecting its deep and diverse intellectual property portfolio. The company´s patents and patents-pending cover a wide variety of areas across multiple discovery programs including CAR T-cell technologies (PCT International Application: PCT/IN2017/050040).